Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03202483

Ligand	Ligand name	Chain	PDB	Tanimoto
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.74
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.7
TES	TESTOSTERONE	A	1JTV	0.77
TES	TESTOSTERONE	A	2Q7L	0.77
TES	TESTOSTERONE	A	2Q7I	0.77
TES	TESTOSTERONE	A,B	1J96	0.77
TES	TESTOSTERONE	A	2Q7K	0.77
TES	TESTOSTERONE	A,B	1Q13	0.77
TES	TESTOSTERONE	H	1I9J	0.77
TES	TESTOSTERONE	A,B	1AFS	0.77
TES	TESTOSTERONE	H	1VPO	0.77
TES	TESTOSTERONE	A	2Q7J	0.77
TES	TESTOSTERONE	A,B	3BUR	0.77
TES	TESTOSTERONE	A	2AM9	0.77
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.78
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.78
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.78
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.78
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.71
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.72
0MA	maslinic acid	A	2QN2	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.76
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.71
C0R	CORTICOSTERONE	A	2A3I	0.79
C0R	CORTICOSTERONE	A,B	1Y5R	0.79
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.76
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.76
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.7
AXT	ASTAXANTHIN	A,B	1GKA	0.72
DEX	DEXAMETHASONE	A,D	1M2Z	0.73
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.73
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.77
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.74
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.74
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.75
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.75
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.71
AS4	ALDOSTERONE	A	2AA2	0.76
AS4	ALDOSTERONE	A	2Q1H	0.76
803	LOVASTATIN	A,B	1CQP	0.71
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.77
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.71
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.71
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.71